Skip to main content

Table 2 Efficacy outcome of AL stratified by age, Bahir Dar district, March to July 2012

From: Assessment of therapeutic efficacy and safety of artemether-lumefantrine (Coartem®) in the treatment of uncomplicated Plasmodium falciparum malaria patients in Bahir Dar district, Northwest Ethiopia: an observational cohort study

Outcome

Age group

Total

5–14 (42)

15–24 (29)

25–34 (29)

35–44 (16)

≥45 (14)

 

No. (%)

No. (%)

No. (%)

No. (%)

No. (%)

No. (%)

ETF

0

0

0

0

0

0

LCF

0

0

0

0

0

0

LPF

0

0

1 (0.8)

0

1 (0.8)

2 (1.56)

ACPR

42 (100)

29 (100)

28 (99.2)

16 (100)

13 (99.2)

128 (98.4)

Total analysis

42

29

29

16

14

130

Withdrew

2

 

0

2

0

5

Total

44

29

29

18

14

134

  1. ETF Early treatment failure, LCF Late clinical failure, LPF Late parasitological failure, ACPR Adequate clinical and parasitological response, With withdrew, No Number, % percent